The agreement that gives Astrea the ability to secure exclusive access to the Affimer technology for applications in bioprocessing... Dec 22
GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform... Dec 22
-Advertisements-